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ABSTRACT
Motivation: High-resolution copy-number (CN) analysis has in
recent years gained much attention, not only for the purpose of
identifying CN aberrations associated with a certain phenotype, but
also for identifying CN polymorphisms. In order for such studies to
be successful and cost effective, the statistical methods have to
be optimized. We propose a single-array preprocessing method for
estimating full-resolution total CNs. It is applicable to all Affymetrix
genotyping arrays, including the recent ones that also contain non-
polymorphic probes. A reference signal is only needed at the last
step when calculating relative CNs.
Results: As with our method for earlier generations of arrays, this
one controls for allelic crosstalk, probe afﬁnities and PCR fragment-
length effects. Additionally, it also corrects for probe sequence
effects and co-hybridization of fragments digested by multiple
enzymes that takes place on the latest chips. We compare our
method with Affymetrix’s CN5 method and the dChip method by
assessing how well they differentiate between various CN states
at the full resolution and various amounts of smoothing. Although
CRMA v2 is a single-array method, we observe that it performs as
well as or better than alternative methods that use data from all
arrays for their preprocessing. This shows that it is possible to do
online analysis in large-scale projects where additional arrays are
introduced over time.
Availability: A bounded-memory implementation that can process
any number of arrays is available in the open source R package
aroma.affymetrix.
Contact: hb@stat.berkeley.edu
Supplementary information : Supplementary data are available at
Bioinformatics online.
1 INTRODUCTION
Following the suite of single nucleotide polymorphism (SNP)
arrays (‘10K’, ‘100K’ and ‘500K’), Affymetrix has released a
new class of chip types referred to as GenomeWideSNP (GWS),
which in addition to SNP units include non-polymorphic probes,
also called copy-number (CN) probes. The latter can be used
∗To whom correspondence should be addressed.
to estimate the amount of target DNA at loci other than SNPs.
The GenomeWideSNP_5 (GWS5), released February 2007, is
targeted by Affymetrix as a genotyping assay, whereas the
GenomeWideSNP_6 (GWS6), released May 2007, is targeted as
both a genotyping and a CN assay.
In this article, we present the CRMA v2 method for estimating
full-resolution raw total CNs. It extends and improves upon
CRMA (Bengtsson et al., 2008b) and applies to all Affymetrix
genotyping arrays including GWS and custom arrays. Likewise, it
does not require genotype calls. The main objective of this method
is to estimate full-resolution CNs so that segmentation and other
downstream analyses can discriminate better between any two CN
states.
In contrast to several other methods, CRMA v2 is a single-array
method that processes each array independently of the others. In
order to achieve this, we had to overcome the challenges in adapting
CRMA’s multi-array steps. Access to a single-array preprocessing
method has several implications: (i) Only two hybridizations are
required for paired analysis, e.g. in a single-person tumor-normal
study, which is further illustrated by the results in Section 3.2. (ii)
Each array can be preprocessed immediately after being scanned.
(iii) Arrays can be processed in parallel on different hosts/processors
making it possible to decrease the processing time of a set of
arrays linearly with the number of processors. (iv) There is no
need to reprocess an array when new arrays are produced, which
further saves time and computational resources. Furthermore, (v)
the decision to filter out poor arrays can be made later, because a
poor array will not affect the preprocessing of other arrays. More
importantly, a single-array method is (vi) potentially very practical
for applied medical diagnostics, because individual patients can be
analyzed at once, even when they come singly rather than in batches.
The outline of this article is as follows. In Section 2, we start
by describing important differences between the new GWS arrays
and the earlier SNP arrays. In light of this, we explain how the
original CRMA (v1) model is adapted for GWS, and how it is further
enhanced by introducing a normalization step controlling for probe
sequence effects. Each step is modified so that it can be applied
to an array independently of the others. At the end of this section,
the evaluation method used for comparing with existing methods is
described. In Section 3, we compare the different methods based on
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Table 1. Summary of the annotation available in the (‘full’) GWS CDFs
GWS5 GWS6
Unit types
SNPs 500 568 931 946
CN units 417 269 945 826
Total 917 847 1 877 772
SNP probe pairs
SNPs with three pairs 0 811 179
SNPs with four pairs 500 568 120 767
SNP alignment
Aligned allele pairs 308 169 931 946
Non-aligned allele pairs 192 399 0
SNP strandness
Sense only 260 266 491 830
Antisense only 194 126 440 116
Opposite strands 46 176 0
Both strands 0 0
their performances at different levels of resolution and stratified by
SNP or CN loci. In Section 4, we conclude the study and give future
research directions.
2 METHODS
2.1 Overview of the GWS arrays
The GWS6 chip type interrogates 931 946 SNPs and 945 826 CN loci totaling
1 877 772 loci, whereas GWS5 interrogates 500 568 SNPs and 417 269 CN
loci totaling 917 837 unique loci. GWS5 has the same set of SNPs as the
500K chip set, whereas for GWS6 6238 of those have been replaced by a
new set of 437 616 SNPs.Among CN loci, only 61 846 are identical on GWS5
and GWS6. In contrast to previous generations of chip types, there are no
mismatches but only perfect-match (PM) probes. On GWS5, all SNPs have
four replicated (PMA, PMB) pairs. On GWS6 there are either three or four
such pairs. These probe pairs are identical replicates, whereas before they
were slightly shifted relative to the SNP position. For both GWS arrays,
the pairs in each SNP were selected so that they optimized the genotype
performance. For the GWS5, there was no constraint that the PMA and PMB
sequences had to be aligned on the genome, causing 192 399 (38.4%) SNPs
to have misaligned PMA and PMB. There was also no constraint that PMA and
PMB should be on the same strand, resulting in 46 176 (9.22%) SNPs with
PMA and PMB on opposite strands. These constraints were reintroduced for
GWS6. The above GWS annotation is summarized in Table 1. More details
on the GWS arrays are available in the Supplementary Material.
For the 100K as well as the 500K SNP-only assays, DNA is prepared
in two parallel processes, each digesting the DNA using a unique enzyme,
amplifying the fragments by PCR, and hybridizing the products to separate
arrays. In the GWS assays, which like 500K, uses the enzymes NspI and StyI,
the two mixes of PCR products are no longer hybridized to separate arrays
but instead to the same array (Affymetrix Inc., 2007a, b). Consequently,
some of the SNP target DNA of PCR products originating from different
restriction digestions (enzymes) will hybridize to the same probe. The non-
polymorphic (CN) probes were designed to target DNA either from both
enzymes or NspI exclusively, but not from StyI alone. For an explanation of
this and a summary of how many SNP and CN loci are targeted by the two
enzymes, see the Supplementary Material.
Finally, for GWS5 and GWS6, Affymetrix has identified 59 744 (6.51%
of all loci) and 25 346 (1.35%) SNPs, respectively, that do not meet their
quality criteria (S.Cawley, Affymetrix, private communication). In order to
differentiate between the filtered and non-filtered sets of loci, Affymetrix
provides one ‘default’ chip definition file (CDF) and one ‘full’ CDF. Further
details on the two types of CDFs are given in the Supplementary Material.
2.2 Proposed model
The CRMA v2 method takes an approach similar to CRMA v1 for estimating
total (non-polymorphic) CNs. The model for allelic-crosstalk calibration is
adapted to GWS, because of the added non-polymorphic probes. After this
calibration, we utilize a nucleotide-position model not only to normalize for
small difference across arrays but also for allelic imbalances in PMA and
PMB. In contrast to our previous multi-array model, we here use a single-
array model to summarize the probes. At the end, PCR fragment-length
normalization is updated to model the multi-enzyme hybridization.
CRMA v2 was designed to be: (i) backward compatible with previous
generations of arrays; (ii) prepared (as far as possible) for future generations
of arrays; (iii) sequential, so that it is easy to replace or add other steps; and
(iv) such that each array can be processed independently of the others. The
latter allows for online single-array CN analysis, which is useful not only
in projects with a very small or a very large number of arrays, but also in
projects where arrays are generated over an extended period of time. It is
only in the last step while calculating relative CNs that a reference is needed.
Although not discussed further in this article, we also look toward a unified
method for estimating allele-specific CNs.
2.2.1 Calibration for offset and crosstalk between alleles For reasons
explained in Bengtsson et al. (2008b), the (PMA,PMB) signals are affected
by allelic crosstalk. It was shown that correcting for crosstalk as well as
offset significantly improved the ability to differentiate between CN states.
The offset & crosstalk model introduced in CRMA v1 needs to be modified
for GWS arrays in order to control for offset in the new non-polymorphic
probes. For SNPs, let xijk = (xijkA,xijkB) and yijk = (yijkA,yijkB) denote the true
and the observed signals for probe pair ( j,k) in SNP j, probe k =1,...,Kj ,
and sample i=1,...,I . Without loss of generality, assume that probes in each
pair are ordered lexicographically by the SNP nucleotides (nts), resulting in
six possible pairs. For a particular pair, we model the allelic crosstalk and
shift observed in {yijk} by an array-specific affine transformation as
yijk = ai +Sixijk +εijk, (1)
where ai = (aiA,aiB)T denotes the offset,
Si =
[
SiAA SiAB
SiBA SiBB
]
(2)
is the crosstalk matrix, and εijk = (εijkA,εijkB)T is noise. In order to avoid
biases in parameter estimates due to aberrant CNs, this model is fitted based
on signals from autosomal chromosomes only, or more generally to a subset
J ∗ of loci that are likely to be copy neutral regardless of sample, i.e.
signals from ChrX and ChrY as well as known CN polymorphic regions
are excluded. If some of the remaining loci are not copy neutral, we rely on
robustness of the estimator to get unbiased estimates. Estimates of the true
signals are obtained by backtransforming as
xˆijk = Sˆ−1i (yijk − aˆi). (3)
In words, the crosstalk correction for SNPs is performed by treating the data
as points sampled from a polyhedral cone in multidimensional space. The
apex (ai) of the cone is the baseline intensity for all channels, and edges
(defined by Si) are directions corresponding to pure signals. Zeroing the
apex and orthogonalizing the edges remove the baseline and the crosstalk.
The cone is fitted iteratively by minimizing the distance from the cone to
the points that lie outside it (Wirapati and Speed, 2002). For other non-
SNP probes, including CN probes, we estimate and correct for the offset as
the weighted average of offsets across all 6 nt pairs with weights inversely
proportional to the number of data points in each group. The reason for
calculating the offset this way is the belief that there is a dominant offset that
is shared by all probes, e.g. scanner offsets (Bengtsson et al., 2004), a view
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which is strengthened by our parallel studies on Affymetrix resequencing
arrays. This would also suggest that the offsets in Equation (1) should be
symmetric in the two alleles and same for all six pairs, but for practical
reasons (Bengtsson et al., 2008b) we do not do this.
Another difference from CRMA v1 is that after correcting for offset,
rescaling to the same arbitrary average (=2200) is based on the median
of all probes pooled together, instead of separately for each nucleotide pair.
This is done to prevent systematic biases between SNP and CN loci due to
enzymatic mixture imbalances.
As in CRMA v1, the above crosstalk calibration method is applied to each
array independently. Despite this, it still controls for gross differences across
arrays (Bengtsson et al., 2008b). In addition to the fact that the crosstalk of
the underlying signals has affine properties, in practice it is the possibility
of rescaling toward a common arbitrary average (instead of, say, an average
across all arrays) that makes this a single-array step.
2.2.2 Normalization for probe sequence effects It has been shown that
the affinity of a probe can be attributed to its sequence composition (Binder
et al., 2004; Carvalho et al., 2007; Naef and Magnasco, 2003; Wu et al.,
2004; Zhang et al., 2007). As in Carvalho et al. (2007), we model the probe
sequence affinity as a function of nucleotide and position in order to control
for (i) small fluctuations in probe affinities across arrays, and (ii) differences
in PMA and PMB affinities. Consider all probes k′ =1,...,K ′ on the array
and let bk′ = (bk′,1,bk′,2,...,bk′,25) be the probe sequence for probe k′ with
nucleotide bk′,t ∈{A,C,G,T} at position t =1,...,25. According to the probe-
position model (Carvalho et al., 2007), the crosstalk and offset calibrated
signals xˆik′ for probe k′ of a given array i=1,...,I , can be described (on the
intensity scale) by:
xˆik′ = ρik′ ·µik′ +ξik′ , (4)
where µik′ is the probe signal of interest, ρik′ >0 is the array- and
sequence-specific affinity, and ξik′ is noise. The affinities are modeled on
the logarithmic scale as:
log2ρik′ = log2ρi(bk′ ) =
∑
b∈{A,C,G,T}
25∑
t=1
I(bk′,t =b)hib(t), (5)
where {hib(·)}b are nucleotide-specific smooth functions and I(·) is the
indicator function. The model is constrained such that
∑
b∈{A,C,G,T}hib(t) = 0
at each position t. We choose to model {hib(·)}b with cubic splines with 5
degrees of freedom (d.f.) (we get very similar results for 7 and 9 d.f.). The
model is fitted on the logarithmic scale with non-positive signals excluded,
and as before, only to the subset of probes that are expected to be copy
neutral. Given estimates {hˆib(·)}b, all probe signals can be normalized as:
y˜ik′ = xˆik′
ρˆi(bk′ )
, (6)
where {y˜ik′ } denotes the offset and crosstalk calibrated and probe-sequence
normalized signals. As in Carvalho et al. (2007), we observe small systematic
effects across arrays {hib(·)}b, which introduce extra variance. In addition,
the difference in affinity between PMB and PMA is hibB (t)−hibA (t), where t is
the SNP probe position. If not controlled for, it will bias heterozygote signals
(AB) relative to homozygote signals (AA or BB), when calculating the total
signals. We note that the latter effect can be controlled for by introducing a
heterozygote component in the crosstalk model, but as argued in Bengtsson
et al. (2008b) such an approach is likely to be sensitive to model errors,
e.g. when there are a lot of CN aberrations which may be the case for some
tumors.
The above method is by design a single-array normalization method.
An alternative, multi-array method, is to replace the correction factor in
Equation (6) with ρRk′/ρˆi(bk′ ), where ρRk′ is calculated as the average effect
across arrays. This would result in smaller adjustments per array while still
normalizing across arrays. However, because of the overall (affine) design
of CRMA v2, such terms (ρRk′ ) cancel out when calculating relative CNs.
2.2.3 Probe-level summarization With technically replicated probes, as
in the most recent chip types GWS5 and GWS6, and assuming that the
effect from neighboring probes is negligible, probe affinities used in multi-
array summarization models will vanish. For these reasons, we consider the
following single-array summarization estimates for total CNs:
y˜ijk = y˜ijkA + y˜ijkB,
θˆij =mediank{y˜ijk}, (7)
where the median is calculated across all probe-pair sums k =1,...,Kj in
SNP j. For older chip types (10–500K) for which the replicated probes are
slightly shifted along the genome, it is still sensible to model the probe
affinities using a multi-array model such as the log-additive model used in
CRMA v1. Since these chip types are considered outdated, we have not
conducted a formal study comparing the two summarization models, but
from our experience we do note a small gain when using the log-additive
model (no such gain is observed for GWS6). Thus, for these arrays, the
choice will be a trade-off of receiving this gain and having the option to
process each array independently of the others.
Finally, for non-polymorphic loci, which are all single-probe units (as
defined by the CDFs used here), we let
θˆij = y˜ij1 (8)
be the corresponding estimates for unit/probe j in sample i. If in future
chip types, or related custom genotyping arrays, there are replicated non-
polymorphic probes, Equation (8) should be replaced by summaries as in
Equation (7).
2.2.4 Normalization for fragment-length effects Because fragments from
two enzymes are hybridized to the same array for GWS, some probes
will match fragments originating from both restriction digestions. See the
Supplementary Material for details on how many SNP and CN loci are
exclusively on NspI, StyI and on both. For signals originating from only one
of the digestions, we could, for each enzyme separately, apply the fragment-
length normalization method proposed in Bengtsson et al. (2008b). However,
because a signal that originates from both digestions consists of one NspI
and one StyI component, which each has been amplified differently, another
method has to be used for such units. For this reason, we modify our previous
model as described next.
First, assume that the number of fragments obtained from digesting with
a particular enzyme is independent of locus j. This assumption was implicit
in CRMA v1. Continuing, let λrj be the length of the fragment that was
digested by restriction enzyme r ∈{Nsp,Sty} and contains locus j. For sample
i=1,...,I , assume that the amount of PCR amplification of a fragment from
digestion with enzyme r ∈{Nsp,Sty} is proportional to 2hri (λrj ), where hri (·)
is a sample-specific smooth function on the logarithmic scale. Next, labeled
PCR products of the two digestions are mixed together. Let ρri >0 be the
total amount of product for enzyme r in sample i relative to the NspI enzyme,
such that ρNspi =1 for all samples. Furthermore, assume that the amount
of target hybridized to a specific probe is proportional to the number of
labeled sequences. When targets from more than one digestion (enzyme)
hybridize to the same probe, assume there is no preference for either enzyme.
Next, let κi >0 be the overall efficiency of hybridization, scanning, image
analysis, etc., for array i relative to the first array, such that κ1 = 1. Finally,
define gri (·) such that 2g
r
i (λrj ) = κiρri 2h
r
i (λrj ) describes, as a scale factor, the
overall systematic effect for locus j in sample i due to fragmentation, PCR
amplification, mixing, hybridization and so on. To conclude, for a probe
interrogating sequences from both digestions, we assume that the signal for
sample i at locus j is proportional to:
2g
Nsp
i (λ
Nsp
j ) +2gStyi (λStyj ) = κi
(
2h
Nsp
i (λ
Nsp
j ) +ρStyi 2h
Sty
i (λ
Sty
j )
)
(9)
We say that the confounded fragment-length effect is additive on the intensity
scale. With this model, each fragment-length effect {gri (·)}r can be estimated
from signals exclusively from a single digestion.
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In Bengtsson et al. (2008b), we normalized the data toward target
fragment-length effects estimated as the average effects across arrays. In the
effort to avoid multi-array estimators in CRMA v2, we here normalize data
toward fixed target effects. The choice of target functions is not important
because the effects will cancel out when CN ratios relative to a reference is
calculated. Using the notation of Bengtsson et al. (2008b), we use constant
target functions grT (λ) = log2(2200), where 2200 was chosen arbitrarily.
Define J Nsp,J Sty,J Nsp∩Sty ⊂J to be the subsets of loci that are
exclusive to NspI, StyI and to both enzymes, respectively. In order to simplify
the notation, we will use the same notation for the true and the estimated
functions. The normalization algorithm for array i=1,...,I is then:
(1) For each enzyme r ∈{Nsp,Sty}, fit a smooth spline gri (·) robustly
to {(λrj ,log2θij)} based on copy-neutral loci j∈J r ∩J ∗ that are
exclusive to restriction enzyme r. This constitutes the fragment-length
effect for enzyme r in the sample i.
(2) For each enzyme r ∈{Nsp,Sty}, calculate the PCR discrepancies for
sample i based on all loci j∈J r that are exclusive to restriction
enzyme r as
log2 δˆij = gri (λrj )−grT (λrj ) (10)
(3) For remaining loci j∈J Nsp∩Sty, calculate the discrepancies as
log2 δˆij = gNsp∩Styi (λNspj ,λStyj )−gNsp∩StyT (λNspj ,λStyj ) (11)
where
gNsp∩Styi (λNsp,λSty) = log2
[
2g
Nsp
i (λNsp) +2gStyi (λSty)
]
, (12)
and gNsp∩StyT (λNsp,λSty) defined analogously.
(4) Finally, normalize all loci (on the intensity scale) by
θ˜ij = θˆij
δˆij
. (13)
Loci for which annotation is missing (see Supplementary Material) are
rescaled such that their median signal equals the median of the other loci. For
chip types such as 10K, 100K and 500K, where there are no multi-enzyme
loci (J Nsp∩Sty =∅), Step 3 no longer applies and the method becomes
effectively identical to the one presented in Bengtsson et al. (2008b) (if the
target effect is estimated from the average array). Moreover, since each gri (·)
includes the term ρri , the above method will also control for imperfect mixing
of enzyme products, which otherwise carry through introducing systematic
effects in loci that originate from both digestions. Analogously, the scale
differences between arrays, {κi}, are also controlled for.
2.2.5 Normalization for GC-content effects As in our previous study, we
did not find any significant GC-content effects remaining after applying
CRMA v2, and correcting for it did not improve the performance. For
this reason, we do not consider GC-content normalization here. We wish to
note that this does not necessarily contradict other studies that report strong
GC-content effects. The reason for this may be due to differences in the
preprocessing methods, especially in how they correct for offset. Consistent
with previous discussion, normalization for GC-content effects can be done
in a single-array manner.
2.2.6 Calculation of raw CNs CRMA v1 and CRMA v2 both calculate
raw CNs as the chip effect relative to a reference. This is the only step in
CRMA v2 requiring a reference. We calculate the relative CN for sample i
and locus j as:
Cij = 2· θ˜ij
θ˜Rj
, (14)
where θ˜Rj is the reference signal, which commonly is the robust average
across samples and possibly corrected for the case that some data points
are from non-copy-neutral loci, cf. Bengtsson et al. (2008b). Note that for
paired studies such as tumor-normal comparisons, the normal DNAwill serve
as the reference, which is why only two hybridizations are needed in such
comparisons. In Equation (14), we assume that the mean of θ˜Rj corresponds
to CN=2, e.g. ChrY reference estimates should be rescaled accordingly. For
CN estimates on the logarithmic scale, we calculate:
Mij = log2
θ˜ij
θ˜Rj
. (15)
Note that the latter is not defined for zero CN levels (or for negative levels
occurring due to noise).
2.2.7 Filtered and non-filtered set of loci Regardless of whether CN
analysis will be conducted on a filtered or the full set of loci, we recommend
that all preprocessing is done on the full set and filtering is applied only
after obtaining raw CNs. The rationale for this is that we believe the main
systematic effects are the same for the filtered and the full set and that one
can estimate these effects more accurately using the latter. This also has the
advantage that the preprocessing will be the same regardless of which set is
used in the end.
2.3 Implementation
The above preprocessing method, referred to as CRMA v2, is available as
part of aroma.affymetrix (Bengtsson et al., 2008a) implemented in R (R
Development Core Team, 2008). The method is designed and implemented
to have bounded-memory usage, regardless of the number of arrays. Since it
is a single-array method, the arrays can be processed in parallel on multiple
hosts/processors.
2.4 Datasets
Two publicly available datasets were used in this study.
2.4.1 Normal dataset GWS6 CEL files for the 30 male and 30 female
CEU founders of The International HapMap Project (Altshuler et al., 2005;
The International HapMap Consortium, 2003) were used. Offspring were
excluded in order to avoid biological relationships. Because female NA12145
has a low true ChrX CN level (Ting et al., 2006), it was excluded from the
evaluation.
2.4.2 Tumor-normal dataset All 68 GWS6 CEL files of the GEO dataset
GSE13372 (Chiang et al., 2009), which among other samples contains 21
replicated tumor-normal HCC1143 (breast ductal carcinoma) pairs, were
processed. The evaluation was done on the first tumor-normal HCC1143
pair. More details on the above datasets can be found in the Supplementary
Material.
2.5 Methods for evaluation
In order to assess the performance of CRMA v2, we compared it
with Affymetrix CN5 method (Affymetrix Inc., 2008) and the method
implemented in dChip (Li and Wong, 2001). For dChip, we found that
summarizing SNP probes by averaging is significantly better than using the
default multiplicative model. For this reason, we only present results for the
former (here denoted by dChip*). Moreover, since the CN5 implementation
is limited to the default CDF, the results presented here are based on that set
of loci. As outlined below, we base the evaluation on the aforementioned data
sets using a multi-sample evaluation and a single-sample single-changepoint
evaluation, respectively. Further details are available in the Supplementary
Material.
2.5.1 Multi-sample ChrX and ChrY evaluation For the normal dataset,
we used the same set of receiver operator characteristics (ROC) evaluation
methods as in Bengtsson et al. (2008b) using relative [Equation (14)]
instead of log-ratio CNs [Equation (15)]. To assess how well the methods
differentiate between one and two copies, and zero and one copy, we use
2152
[11:38 4/8/2009 Bioinformatics-btp371.tex] Page: 2153 2149–2156
CRMA v2
ChrX and ChrY data, respectively. We exclude loci in pseudo-autosomal
regions (Blaschke and Rappold, 2006) and inside and close to known CN
polymorphic regions (Redon et al., 2006), leaving 68 966 ChrX loci and 5718
ChrY loci. Since CN5 uses only females (males) for the reference signals
{θ˜Rj} on ChrX (ChrY), this comparison study will not use bias-corrected
reference signals from all samples (Bengtsson et al., 2008b).
2.5.2 Single-sample evaluation at a set of changepoints For the tumor-
normal dataset, we selected one tumor-normal pair for which we identified a
set of regions each containing a single CN change point. Data points in a 500
kb region centered on each change point were excluded. The remaining data
points are annotated to belong to either the copy-neutral state or the copy-
aberrant state. Contrary to the evaluation on the normal dataset, the true
CN levels are not known except that they are either gains or losses. Next,
for each CN region we use ROC analysis to assess how well the raw CNs
separate between the neutral and the aberrant data points. This evaluation is
done on the full-resolution CNs as well as smoothed CNs, where the CNs
are smoothed by using non-overlapping bins for which the average of CNs is
calculated. This approach was inspired by studies such as Lai et al. (2005),
Willenbrock and Fridlyand (2005) as well as Bengtsson et al. (2009).
3 RESULTS
3.1 Multi-sample evaluation
3.1.1 Differentiating CN = 1 and CN = 2 (ChrX) As explained in
detail in Bengtsson et al. (2008b), we use ChrX data to assess how
well a set of CN estimates can differentiate between the CN = 2
(females) state and the CN = 1 (males) state. The idea is to call the
CN state for each locus given a global threshold, where a locus with
a CN estimate below the threshold is considered to belong to the
CN = 1 state, otherwise the CN = 2 state. By calculating the fraction
of correctly called CN = 1 loci, we obtain an estimate of the true-
positive rate, and by calculating the fraction of incorrectly called
CN = 2 loci, we obtain an estimate of the false-positive rate. By
adjusting the threshold, we can estimate the ROC curve. The true-
positive rate of calling a CN = 1 locus correctly (among CN = 2 loci)
as a function of false-positive rate is depicted in Figure 1 for each of
the three methods. The ROC curves show that CRMA v2 separates
CN = 1 from CN = 2 better than CN5, which in turn is better than
dChip*. This is true both at the full resolution (H =1) and at various
amounts of smoothing. We also note that CRMA v2 smoothed with
three loci per window performs as well as or better than dChip*
smoothed with four loci per window (see also Fig. 2). In this ROC
analysis, which is based on 68 966 loci in 59 samples, there were in
total 2 000 014 CN = 1 (male) loci out of 4 068 994 loci.
Using a windowing technique similar to that in Bengtsson et al.
(2008b), for a fixed false-positive rate we can estimate the true-
positive rate as a function of amount of smoothing. Since a given
amount of smoothing corresponds to a given distance between loci
this provides us with a first approximation to the effective resolution
of a method. In Figure 2A, the true-positive rate (for CN = 2 versus
CN = 1) as a function of resolution is shown for the three methods,
which shows that CRMA v2 has a higher resolution.
3.1.2 Differentiating CN = 0 and CN = 1 (ChrY) Identifying a
CN = 0 locus among CN = 1 loci is easier than identifying a CN = 1
locus among CN = 2 loci. This is because the distance between
CN = 0 and CN = 1 is greater than that between CN = 1 and CN = 2,
relative to the reference level (and noise level). This is also confirmed
A B
Fig. 1. ROC curves showing that CRMA v2 (solid red) separates CN = 1
from CN = 2 (ChrX) better than CN5 (dashed blue) and dChip* (solid light
blue) at the full resolution (H =1; A) as well as at various amounts of
smoothing (H =1,2,3,4; B). The curves for H =1 are in the lower right
corner and the curves for H =4 are in the upper left corner.
A
B
Fig. 2. The true-positive rate as a function of resolution/smoothing at a 2.0%
false-positive rate for the different methods. The results for the CN = 2 versus
CN = 1 (ChrX) test is depicted in (A) and the results for the CN = 1 versus
CN = 0 (ChrY) test in (B). Note the different scales. See Figure 1 for legends.
by comparing the corresponding true-positive rates at a given false-
positive rate (Figs 1 and 3) at the full resolution or at various amounts
of smoothing (Fig. 2). The results also show that CN5 is as good
as or slightly better than CRMA v2 at differentiating CN = 0 from
CN = 1, and both are better than dChip*. In this ROC analysis, which
is based on 5718 loci in 59 samples, there were in total 150 162
CN = 0 (female) loci out of 305 502 loci.
3.1.3 Performance of SNPs and CN loci In order to better
understand differences between methods, we compare the ROC
curves and distribution of true-positive rates at a given false-positive
rate, while stratifying on SNP and CN loci. We observe that on
average the discriminatory power is greater for SNPs than CN loci
(Fig. 4). CN5 is the method for which SNPs and CN loci have
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A B
Fig. 3. ROC curves showing CRMA v2 differentiates between CN = 1 and
CN = 0 (ChrY) as well as or slightly worse than CN5, and better than dChip*
at the full resolution (A) as well as at various amounts of smoothing (B). See
Figure 1 for legends.
Fig. 4. The methods’performances on SNPs (left) and CN units (right) when
testing for CN = 2 versus CN = 1 (ChrX; upper) and CN = 1 versus CN = 0
(ChrY; lower). The panels show the ROC curves for CRMA v2 (solid red),
CN5 (dashed blue) and dChip* (solid light blue) at H =1,2,3,4 amounts of
smoothing.
the most similar performances. Furthermore, by investigating the
locus-by-locus ROCs, we observe that the true-positive rates at a
fixed false-positive rate tend to be greater for SNPs than for CN loci
(Fig. 5), and that there is a significant set of CN loci with very low
true-positive rates. The dChip* method has a larger set of poorly
performing CN loci, which is also seen when comparing dChip’s
ROC curves for SNPs and CN loci. For the ChrX-based analysis,
30 238 SNPs and 38 728 CN loci were used, and for the ChrY-based
analysis, 208 SNPs and 5510 CN loci were used.
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Fig. 5. Distribution of true-positive rates for SNPs (A and C) and CN units
(B and D) for CRMA v2 (left bars; red), CN5 (middle bars; blue) and dChip*
(right bars; light blue) when testing for CN = 2 versus CN = 1 (ChrX; A and
B) and CN = 1 versus CN = 0 (ChrY; C and D) while fixing the false-positive
rate (3.45%). No smoothing was applied.
3.2 Single-sample evaluation
For the tumor-normal pair HCC1143, we calculated how well CN
estimates of loci that are either gains or losses separate from
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Fig. 6. The region 100.1–107.5 Mb on Chr 1 in tumor-normal sample
HCC1143 has a change point at ∼103.8 Mb, which separates a copy-neutral
state (left) from a loss (right). There are 2242 and 2074 loci in these two
states, respectively (totaling 4316 loci). The top three rows show the raw
CNs [Equation (14)] of the CRMA v2, the dChip and the CN5 methods,
respectively. The 500 kb safety region around the change point with data
points excluded in the evaluation is highlighted by a dashed frame. The three
panels in the bottom row show the ROC performance of the three methods
at the full resolution, and after binning the CNs in non-overlapping windows
of size 5 and 20 kb, respectively. See Figure 4 for legends.
estimates of copy-neutral loci. Figures 6 and 7 show the CN
estimates and the performance for a 7.4 Mb region on Chr 1 and
a 9.0 Mb region on Chr 10, respectively. The former contains a loss
(2074 out of 4316 loci) and the latter a gain (2805 out of 5285 loci).
The ROC results show that CRMA v2 identifies the aberrant states
better than or as well as dChip* and CN5. We wish to emphasize
that in order for CRMA v2 to provide CN estimates for this tumor-
normal pair only two CEL files were required. For dChip* and CN5,
all 68 CEL files were used in order to obtain CN estimates. Results
for additional CN regions and amounts of smoothing can found in
the Supplementary Material.
4 DISCUSSION
We conclude that it is possible for a single-array method such
as CRMA v2 to produce non-polymorphic CN estimates that
discriminate two CN states as well as or better than existing
multi-array-based methods. In the above sections, we have tried to
point out the main attributes of each preprocessing step that allow
Fig. 7. The region 61.0–69.0Mb on Chr 10 in tumor-normal sample
HCC1143 has a change point at ∼65.3 Mb, which separates a gain (left)
from a copy-neutral state (right). There are 2805 and 2480 loci in these two
states, respectively (totaling 5285 loci). See Figure 6 for content and legends
as in.
CRMA v2 to become a single-array method. In order to further
clarify why this is possible, we would like to underline that there
is a distinction between models that include parameters shared by
multiple arrays, and algorithms that are applied to multiple arrays.
The main rationale for using multi-array models (Li and Wong,
2001), was removed when Affymetrix designed the newer arrays to
have identically replicated SNP probes. Having said this, we believe
that several existing preprocessing methods, such as CN5 and dChip,
naturally allow themselves to be turned into single-array methods
(without having to rely on a priori parameter estimates).
Confirming previous observations, we found that it is harder
to differentiate between CN = 1 and CN = 2 than between CN = 0
and CN = 1. We believe that this trend will be true for higher CN
levels, i.e. it will be increasingly difficult to separate higher CN
levels from each other. We also found that the SNPs show better
discrimination for CN than the CN loci. We look forward to further
studies investigating whether this is because more/multiple probes
are used for the SNPs or there are other reasons for this. Also,
an assessment is still needed of how well CRMA v2 (and other
methods) controls for systematic effects between labs and batches,
and whether additional normalization is needed in such cases.
We also wish to emphasize that the dChip method has not been
optimized for GWS or SNP arrays, which may explain its lower
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performance in this GWS6 study in comparison with its higher
performance for the 500K arrays (Bengtsson et al., 2008b).
CRMA v2 provides neither allele-specific nor CN estimates
calibrated toward true CN levels. Allele-specific CNs are needed in
order to identify events such as copy-neutral loss-of-heterozygosity
(LOH). With calibrated allele-specific CNs, genotyping algorithms
can be generalized to call genotypes beyond the traditional diploid
AA, AB and BB states. We are currently working on an extension to
CRMA v2 that will provide full-resolution calibrated allele-specific
CN estimates.
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